LifeSenz Cancer Research Labs (www.lifesenz.co.in) is a biomedical R&D based company. We are ISO 9001:2015 certified with startup India (DIPP 103053), local FDA approved and National Skill Development Corporation, India (LSSSDC) affiliated company.
LifeSenz is working in three domains:
1. Personalized cancer therapy prediction model: Therapy prediction is a challenge in cancer and considering both time and money is critical for cancer management, LifeSenz has developed a patient biopsy derived ex vivo based 3D cancer model (mimicking in vivo physiology) which can predict therapeutic drug efficacy before the clinical treatment begins; thereby it can reduce the effective treatment cost, minimize non-effective treatment mediated side effects but also improve therapeutic efficacy. At present LifeSenz is processing the clinical validation study with various channel partners across India.
2. Translational Research: Both In house and collaborative research as well as consultancy/servicebased research engagements helps us to better understand the unmet challenges of various metabolic diseases such as cancer, osteoarthritis etc but also assist us to identify better drug development or identification. In this regard LifeSenz already collaborates with multiple research partners (academia/ industry) across India and provides scientific services to the community.
3. Scientific Training and Development: Utilizing current laboratory infrastructure, LifeSenz is currently engaged to train and upskills biopharma students (under/postgrads/PhD in any stream of LifeSciences) through various short and long-term research-based industry relevant technical training programs. In this regard LifeSenz already in collaboration with multiple research based institutions across India and provides industry relevant technical training and services to the community. Thereby it is contributing in generating future ready high skilled human resources for global biopharma entities.